Karolinska

Karolinska Development AB is an investment firm focused on identifying and nurturing medical innovations. It invests in companies that develop these innovations into products aimed at improving patient outcomes and achieving robust financial returns. The company leverages access to cutting-edge medical research from institutions like the Karolinska Institutet, aiming to build successful ventures around leading scientists. Karolinska Development manages a portfolio of 10 companies focused on innovative treatments for severe diseases. Its leadership includes venture capital experts, experienced entrepreneurs, and a global network of specialists.